Table 5.
Predictors of Symptom Severity at 10 Weeks
| Variable | β | df | Type III SS | F | p |
|---|---|---|---|---|---|
| Group | 6.66 | 1 | 1,003.31 | 4.39 | 0.04 |
| Control | - | - | - | - | - |
| Intervention | - | - | - | - | - |
| Symptom severity at baseline | 0.30 | 1 | 1,591.71 | 6.96 | 0.01 |
| Gender | -1.95 | 1 | 51.07 | 0.22 | 0.64 |
| Female | - | - | - | - | - |
| Male | - | - | - | - | - |
| Age | -0.01 | 1 | 1.14 | - | 0.94 |
| Depressive symptoms at baseline | 0.41 | 1 | 585.54 | 2.56 | 0.11 |
| Site of cancer | - | 3 | 1,302.40 | 1.90 | 0.14 |
| Breast | 3.28 | - | - | - | - |
| Other | 9.33 | - | - | - | - |
| Lung | 3.47 | - | - | - | - |
N=113
Note. All Possible interactions were tested